课题基金 / 基金详情

MicroRNAs regulate skin Langerhans cells

MicroRNAs regulate skin Langerhans cells
MicroRNA 调节皮肤朗格汉斯细胞
批准号:
10250383
负责人:
Li Zhou
金额:
$32.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-08-31

项目摘要

项目成果

Li Zhou的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 郎格汉斯细胞(LCS)是驻留在皮肤上的树突状细胞(DC),控制着 获得性免疫和皮肤免疫耐受参与多种皮肤病 发展。然而,监管机制所涉及的发展和功能 LCS的致病机制尚未完全阐明。MicroRNAs(MiRNAs),一类非编码的小分子 RNAs,被认为是蛋白质编码基因的重要调节因子,通过抑制 信使核糖核酸翻译。利用Cre-loxP缺失小鼠模型,我们的实验室和其他人已经 报道称,CD11c-Cre或hLangerin-Cre删除miRNAs显著降低了 编号并中断了LCS的功能,表明LC需要miRNAs 出生后的动态平衡和功能。虽然有1000多个实验报告 MiRNAs,到目前为止,很少有单个miRNAs与LC相连。我们是第一个报道 MIR-150和miR-223对LC诱导的T细胞增殖和细胞因子的差异调节 制作。最近,我们的胚胎谱系追踪研究表明,miRNAs,包括 MIR-17-92簇,调控LC胚胎发育。此外,使用miRNA阵列,我们 与未成熟LC相比,成熟LC具有独特的miRNA基因表达谱 该miRNA表达在LC胚胎个体发育过程中动态变化。这些 这些发现导致了我们的中心假设,即动态变化的miRNAs可能作为 通过微调特异性调控LC个体发育、内稳态和功能的关键调节因子 靶基因。在目标1中,我们将研究miRNAs在LC个体发育和动态平衡中的作用。 结构性或可诱导的CSF1R特异的单个miRNA突变小鼠将用于研究 胚胎LC个体发育和炎症后LC再繁殖,而LC特异性Disher或 单个miRNA突变小鼠出生后将用于LC动态平衡。在目标2中,我们将 研究miRNAs在LC功能、可诱导的LC特异性DICER或单个miRNA中的作用 将使用突变小鼠模型。在目标3中,miRNAs的直接靶基因(S)及其相关基因 参与LC发育和功能的信号通路将由 RNA-seq、miRNA生物信息学的结合及相关靶标功能验证 战略。拟议的研究将揭示miRNA-mrna的动态调控和相关 控制LC发育和功能的分子机制和信号通路 不仅将为LCS的生物学提供新的见解,而且还可能促进LCS的发展 以LC为基础的疾病干预策略。
英文摘要
Abstract Langerhans cells (LCs), the skin residing dendritic cells (DCs), control both the induction of adaptive immunity, and immune tolerance in skin and are involved in variety of skin disease development. However, the regulatory mechanisms involved in the development and functions of LCs have not been completely elucidated. MicroRNAs (miRNAs), a class of non-coding small RNAs, are recognized as important regulators of protein-coding genes through the inhibition of mRNA translation. Using Cre-loxP Dicer deletion mouse models, our laboratory and others have reported that deletion of miRNAs by CD11c-Cre or hLangerin-Cre significantly reduced the number and interrupted the function of LCs, indicating that miRNAs are required for LC homeostasis and function after birth. While there are more than 1000 experimentally reported miRNAs, very few individual miRNAs are linked to LCs so far. We were the first to report that miR-150 and miR-223 differentially regulated LC-induced T cell proliferation and cytokine production. Most recently, our embryonic lineage-tracing studies showed that miRNAs, including miR-17-92 cluster, regulate LC embryonic development. Furthermore, using miRNA arrays, we identified that mature LCs have a unique miRNA gene expression profile compared to immature LCs, and that miRNA expression is dynamically changed during LC embryonic ontogeny. These findings led to our central hypothesis that the dynamically changed miRNAs may serve as critical regulators controlling LC ontogeny, homeostasis and function through fine-tuning specific target genes. In Aim 1, we will investigate the roles of miRNAs in LC ontogeny and homeostasis. Constitutive or inducible Csf1r-specific individual miRNA mutant mice will be used for studying embryonic LC ontogeny and LC repopulation after inflammation, while LC-specific Dicer or individual miRNA mutant mice will be used for LC homeostasis after birth. In Aim 2, we will investigate the roles of miRNAs in LC function, inducible LC-specific Dicer or individual miRNA mutation mouse models will be used. In Aim 3, the direct target gene(s) of miRNAs and related signaling pathways involved in LC development and function will be investigated by the combination of RNA-seq, miRNA bioinformatics and related target functional validation strategies. The proposed studies will uncover the dynamic miRNA-mRNA regulation and related molecular mechanisms and signaling pathways that control LC development and function, which will not only provide new insight into the biology of LCs, but may also facilitate the development of LC-based intervention strategies for diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
  • 批准号:
    10228607
  • 项目类别:
  • 资助金额:
    $69.75万
  • 财政年份:
    2019
  • 负责人:
    Li Zhou
  • 依托单位:
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
  • 批准号:
    10018800
  • 项目类别:
  • 资助金额:
    $69.62万
  • 财政年份:
    2019
  • 负责人:
    Li Zhou
  • 依托单位:
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
  • 批准号:
    10470022
  • 项目类别:
  • 资助金额:
    $70.25万
  • 财政年份:
    2019
  • 负责人:
    Li Zhou
  • 依托单位:
Improving Allergy Documentation and Clinical Decision Support in the EHR
  • 批准号:
    9915842
  • 项目类别:
  • 资助金额:
    $39.41万
  • 财政年份:
    2018
  • 负责人:
    Li Zhou
  • 依托单位:
海外基金